75F40124A00021↗
International Consulting Associates, Inc. received this contract vehicle from Fda Office of Acq Grant Svcs, Food and Drug Administration: $0 obligated so far for support- professional: other. It runs to 2027-08-12.
Key facts · data as of Oct 23, 2026
- Recipient
- International Consulting Associates, Inc.
- Awarding agency
- Food and Drug Administration (Department of Health and Human Services)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Obligated to date
- $0
- Potential value
- $98.83M
- Ends
- 2027-08-12
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75F40124A00021, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_IDV_75F40124A00021_7524
International Consulting Associates, Inc.: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys · The follow-on: recompete brief
ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS
Up for re-bid: ends 2027-08-12. Recompete brief →
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Other Computer Related Services (NAICS 541519)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Competition
- Full and open competition · 2 offers received
- Set-aside
- Small business
- Pricing
- Labor hours
- How it was bought
- Contract vehicle (IDV) itself · under 47QTCA23D007W
- Solicitation
- 75F40124Q00260
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Orders under this vehicle
5 orders worth $78.33M (current value). The largest:
- 75F40124F19001 · $30.27M · ends 2027-09-03
- 75F40125F19002 · $20.59M · ends 2027-06-03
- 75F40125F19003 · $13.30M · ends 2027-09-18
- 75F40126F19005 · $12.09M · ends 2027-09-13
- 75F40125F19004 · $2.09M · ends 2026-09-29
Every action
4 actions since 2024-08-13. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-15 | P00003 | Option exercised | $0 | ADMIN MOD TO CORRECT ORDERING END DATE IN SYSTEM - ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS |
| 2025-09-12 | P00002 | Administrative change | $0 | ADMIN MOD TO CORRECT ORDERING END DATE IN SYSTEM - ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS |
| 2025-07-25 | P00001 | Administrative change | $0 | EXERCISE THE OPTION I ORDERING PERIOD - ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS |
| 2024-08-13 | 0 | $0 | ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗